CytomX Therapeutics (CTMX) Preferred Shares (2014 - 2015)
CytomX Therapeutics (CTMX) reported Preferred Shares of $474000.0 for Q3 2015, down 99.38% quarter-over-quarter from $76.2 million in Q4 2014.
CytomX Therapeutics (CTMX) Preferred Shares (2014 - 2015) Analysis & Trends
CytomX Therapeutics has reported Preferred Shares for 2 years, with the latest figure at $474000.0 in Q3 2015.
- For the quarter ending Q3 2015, Preferred Shares changed N/A year-over-year to $474000.0; the trailing twelve-month figure through Sep 2015 stood at $474000.0 (changed N/A YoY), and the FY2014 full-year result was $76.2 million, changed N/A from the prior year.
- Preferred Shares for Q3 2015 stood at $474000.0, down from $76.2 million in the prior quarter.
- The five-year high for Preferred Shares was $76.2 million in Q4 2014, with the low at $474000.0 in Q3 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | CytomX Therapeutics | 520.30 Mn | 173.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 474,000.00 |
| Dec 31, 2014 | 76.24 Mn |